Area of research
Epidemiology · Oncology
Research interest
Research interests include Cervical Cancer and HPV Research, Global Cancer Incidence and Screening, Reproductive tract infections research, and Vaccine Coverage and Hesitancy.
Cervical screening approach of self-collection, point-of-care HPV testing, and same-day colposcopy among Aboriginal and Torres Strait Islander women in remote Western Australia (the PREVENT Project): an implementation study
The impact of alternate HPV vaccination and cervical screening strategies in Japan: a cost-effectiveness analysis
Understanding the Challenges of HPV-Based Cervical Screening: Development and Validation of HPV Testing and Self-Sampling Attitudes and Beliefs Scales
COVID-19 as a catalyst for reimagining cervical cancer prevention
Corrigendum to “Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis” [Vaccine 40(41) (2022) 5971–5996]
Human papillomavirus vaccine effectiveness by number of doses: Updated systematic review of data from national immunization programs
Aboriginal and Torres Strait Islander women's views of cervical screening by self‐collection: a qualitative study
Measuring school level attributable risk to support school-based HPV vaccination programs
Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis
School-based HPV vaccination positively impacts parents’ attitudes toward adolescent vaccination
Effect of a School-Based Educational Intervention About the Human Papillomavirus Vaccine on Psychosocial Outcomes Among Adolescents
Levels of anxiety and distress following receipt of positive screening tests in Australia’s HPV-based cervical screening programme: a cross-sectional survey
Vaccine Preventable Diseases and Vaccination Coverage in Aboriginal and Torres Strait Islander People, Australia, 2011–2015
The projected timeframe until cervical cancer elimination in Australia: a modelling study
The impact of 10 years of human papillomavirus (HPV) vaccination in Australia: what additional disease burden will a nonavalent vaccine prevent?
Very Low Prevalence of Vaccine Human Papillomavirus Types Among 18- to 35-Year Old Australian Women 9 Years Following Implementation of Vaccination
A Prospective Study of the Incidence of Juvenile-Onset Recurrent Respiratory Papillomatosis After Implementation of a National HPV Vaccination Program
Safety of Human Papillomavirus Vaccines: An Updated Review
Progress in HPV vaccination in low‐ and lower‐middle‐income countries
Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial
HPV vaccination of immunocompromised hosts
Looking beyond human papillomavirus (HPV) genotype 16 and 18: Defining HPV genotype distribution in cervical cancers in Australia prior to vaccination
Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
The first comprehensive report on Indigenous Australian women's inequalities in cervical screening: A retrospective registry cohort study in Queensland, Australia (2000‐2011)
Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
Interim estimates of male human papillomavirus vaccination coverage in the school-based program in Australia
Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
Safety of Human Papillomavirus Vaccines: A Review
Human papillomavirus vaccine coverage among female Australian adolescents: success of the school‐based approach